Emergent BioSolutions (EBS) EBITDA (2011 - 2026)
Emergent BioSolutions (EBS) reported EBITDA of -$101.1 million for Q2 2026, compared with $25.1 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBITDA (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Emergent BioSolutions' EBITDA came in at $28.4 million, down 86.3% year-over-year; for FY2025, it came in at $195.9 million.
- EBITDA has a five-year compound annual growth rate of -18.7% (FY2020 to FY2025).
- By year, EBITDA came in at $100,000 in FY2024, -$601.3 million in FY2023, -$26.7 million in FY2022 and $465.2 million in FY2021 (-15.9%).
- The Q2 2026 figure ranks as the lowest quarterly EBITDA since Q2 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at $34 million (Q1 2026), -$4.4 million (Q4 2025) and $99.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn | -99.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -99.50 Mn |
| Mar 31, 2026 | 35.80 Mn |
| Dec 31, 2025 | -1.80 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Jun 30, 2025 | 27.50 Mn |
| Mar 31, 2025 | 77.60 Mn |
| Dec 31, 2024 | 18.70 Mn |
| Sep 30, 2024 | 84.20 Mn |
| Jun 30, 2024 | -170.00 Mn |
| Mar 31, 2024 | 74.60 Mn |
| Dec 31, 2023 | -8.50 Mn |
| Sep 30, 2023 | -208.40 Mn |
| Jun 30, 2023 | -251.10 Mn |
| Mar 31, 2023 | -112.00 Mn |
| Dec 31, 2022 | -18.60 Mn |
| Sep 30, 2022 | -12.00 Mn |
| Jun 30, 2022 | -30.80 Mn |
| Mar 31, 2022 | 38.80 Mn |
| Dec 31, 2021 | 317.00 Mn |
| Sep 30, 2021 | -10.90 Mn |
API Access
Emergent BioSolutions EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();